Last week we hosted the BGO Life Sciences & AI Forum - two days of focused discussions across pharma, #clinicalresearch, #digitalhealth, and #AI. Across sessions and conversations, several themes consistently emerged. Check the comments to find out.๐
QbC is #QbD made active. QbD defines the operating space; QbC keeps the process inside it under real #manufacturing conditions.๐
https://t.co/2ByXPnoqIv
Pharmaceutical manufacturing demands absolute precision. Computer System Validation (CSV) exists to prove digital tools work exactly as intended for #patientsafety.๐#CSV
https://t.co/dmMcRy2zhD
Downstream #bioprocessing accounts for somewhere between 60% and 80% of the total #production cost of a #biologicdrug. That number gets quoted often.๐ https://t.co/rzoXpWXzko
How the BGO Life Sciences & AI Forum brought together practitioners resulted in multydisciplinary network in the chase of supporting the #lifesciecnce and #healthcare.๐
https://t.co/pLg4gPCRN6
Fragmented data across historians, #LIMS, #MES, and #batchrecords is the primary reason most organisations cannot detect interaction-driven yield losses even when the data to find them already exists.๐
https://t.co/KTI7K61RYc
Medical coding is the process of converting diagnoses, procedures, and medical services into standardized alphanumeric codes based on medical records.๐#healthcarebilling
https://t.co/uszZ4HSdAR
The #URS is your foundation: Itโs the single most important document in the system #development#lifecycle โ everything else is built on it.๐
https://t.co/vbK2atC58O
Enter real-time #monitoring โ the technology thatโs finally giving #healthcare providers the truth about what happens when #patients walk out the door.๐
https://t.co/8ktsvHsamJ
The FDAโs own self-audit found that continuous #manufacturing applications had shorter approval times and earlier market entry than comparable batch #submissions, translating to an estimated $171โ537 million in early revenue benefit per #product.๐
https://t.co/HOc9YkOWYJ
Have you ever wondered what makes some #healthcare#software grow fast and serve millions, while others struggle to keep up? The answer often lies behind the scenes โ in the tech stack. A tech stack is more than mere code. It is the foundation on which an entire system is built.
#Digitalvalidation tools transform how #pharmaceutical manufacturers manage validation lifecycles in #GxP regulated environments, reshaping team collaboration, data integrity maintenance, and speed-to-market timelines.ย ๐
https://t.co/9W9fFoBvv0
Research indicates that approximately 25% of #FDA enforcement letters include violations related to data validity or fitness-for-purpose evidence. These failures typically stem from poor #lifecycle control.๐ #pharmamanufacturing#csv
https://t.co/dmMcRy2zhD
#KIMES 2026 wrapped ๐ฐ๐ท A truly valuable opportunity to connect with companies across #digitalhealth, medical #technology, and AI from Korea and across the wider APAC region.
If your sterile #manufacturing site passed its last inspection, EU #GMP Annex 1 may still be exposing a gap you havenโt fully closed.๐
https://t.co/Z0myp8muWE
๐ Data quality is no longer just a compliance topic, itโs the foundation of AI adoption.
๐ And last but not least... Behind every system, every dataset, every model - there are real people impacted.
Last week we hosted the BGO Life Sciences & AI Forum - two days of focused discussions across pharma, #clinicalresearch, #digitalhealth, and #AI. Across sessions and conversations, several themes consistently emerged. Check the comments to find out.๐
๐ Organizations with mature processes accelerate. Those without - introduce more complexity.
๐ In regulated environments, speed and compliance are not opposites, they must be intentionally balanced.